Leaving History Behind: CD4/CD8 Ratio as a Diagnostic Tool in Sarcoidosis

Abstract

Article history: Received 1 May 2016 Accepted 1 May 2016 Available online 5 May 2016 methodology. These have resulted in significant clinical trial heterogeneity. Of the 16 studies included by Shen, 1 was blinded, 5 were retrospective, and there was variability in CD4/CD8 ratio cut-points and sarcoidosis diagnostic criteria. Significant heterogeneity still existed when the authors performed a sensitivity analysis of prospective studies with low risk of bias.

DOI: 10.1016/j.ebiom.2016.05.002

Extracted Key Phrases

Cite this paper

@inproceedings{James2016LeavingHB, title={Leaving History Behind: CD4/CD8 Ratio as a Diagnostic Tool in Sarcoidosis}, author={William E. James}, booktitle={EBioMedicine}, year={2016} }